tailieunhanh - Azithromycin for Indigenous children with bronchiectasis: Study protocol for a multi-centre randomized controlled trial

The prevalence of chronic suppurative lung disease (CSLD) and bronchiectasis unrelated to cystic fibrosis (CF) among Indigenous children in Australia, New Zealand and Alaska is very high. Antibiotics are a major component of treatment and are used both on a short or long-term basis. | Azithromycin for Indigenous children with bronchiectasis: Study protocol for a multi-centre randomized controlled trial

TỪ KHÓA LIÊN QUAN